On June 13, 2022, plaintiffs won a series of procedural victories in the kidney and bone injury lawsuit filed against pharma giant Gilead Sciences when California Superior Court Judge Andrew Y.S. Cheng denied three summary judgment motions filed by Gilead seeking to dismiss the litigation. Since the dangers from Gilead’s prescription medications (Truvada® and Atripla®) that
On February 5, 2020, Judge Andrew Y.S. Cheng of the Superior Court for the County of San Francisco issued an order appointing Lieff Cabraser partner Sarah R. London to the Plaintiffs’ Executive Committee in the Gilead HIV Drug Kidney & Bone Injuries Litigation. Sarah will lead the litigation on behalf of patients across California who allege they suffered kidney
In lawsuits against pharma giant Gilead Sciences, plaintiffs across California allege they suffered ill effects from HIV drugs made and distributed by Gilead that were more harmful derivatives than other drugs the company had created but not sold until its stock of the inferior drugs was exhausted. As reported by the Daily Journal (subscription), attorneys